Characterisation of antibody responses induced by BCG and other TB vaccines to inform future vaccine design
Tuberculosis (TB) remains a pressing global health challenge. The focus of TB vaccine research traditionally centres on either enhancing BCG's efficacy or identifying a suit-able alternative. Within this context, antibody responses, a potentially relevant corre-late of protection, are inadequat...
1. Verfasser: | Peralta Alvarez, MP |
---|---|
Weitere Verfasser: | Tanner, R |
Format: | Abschlussarbeit |
Sprache: | English |
Veröffentlicht: |
2023
|
Schlagworte: |
Ähnliche Einträge
Ähnliche Einträge
-
Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates
von: Marco Polo Peralta Alvarez, et al.
Veröffentlicht: (2024-05-01) -
Need for BCG Vaccination to Prevent TB in High-Incidence Countries and Populations
von: Shalini Pooransingh, et al.
Veröffentlicht: (2020-03-01) -
Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine
von: Nancy Gupta, et al.
Veröffentlicht: (2018-10-01) -
Commentary: Bettering BCG: a tough task for a TB vaccine?
von: Brahm S. Srivastava, et al.
Veröffentlicht: (2019-09-01) -
Mantoux test results and BCG vaccination status in TB-exposed children
von: Fadilah Harahap, et al.
Veröffentlicht: (2015-03-01)